Genetic testing in breast/ovarian cancer (BRCA1) families

The Lancet

Volumn 346, Issue 8974, 1995, Pages 583-

  Watson, M ^a,b,c   Murday, V ^b,c   Lloyd, S ^b,c   Ponder, B ^b,c   Averill, D ^b,c   Eeles, R ^b,c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; BREAST CANCER; CANCER DIAGNOSIS; CANCER GENETICS; CANCER RESEARCH; ETIOLOGY; FAMILIAL CANCER; FEMALE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SCREENING; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HUMAN EXPERIMENT; LETTER; MALE; MENTAL HEALTH; MOLECULAR CLONING; MOTIVATION; NORMAL HUMAN; OVARY CANCER; PATIENT COUNSELING; PRIORITY JOURNAL; PROGENY;

EID: 0029121898     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)91424-2     Document Type: Letter

References (3)

1. A strong candidate for the breast and ovarian susceptibility gene BRCA1
2. Genetic linkage in familial breast and ovarian cancer: results from 214 families
3. Uptake of presymptomatic predictive testing for Huntington's Disease